First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Research explores DNA methylation clock accuracy across tissues February 12, 2025 Paternal and maternal transplants boost infant gut health after cesarean delivery June 16, 2024 New combined cell therapy for kidney transplants can help reduce donor-specific immune response July 22, 2024
New combined cell therapy for kidney transplants can help reduce donor-specific immune response July 22, 2024